Skip to main content
PMC home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;30(6):388–391. [Article in Spanish] doi: 10.1016/S0212-6567(02)79052-5

Reflexiones sobre la investigación de resultados en salud

X Badia Llach a,*, L Lizán Tudela b
PMCID: PMC7677987  PMID: 12396946

The content is available as a PDF (230.8 KB).

Bibliografía

  • 1.American Medical Association . Principles of Outcomes Research. Outcomes Research Resource Guide, 1996/97. American Medical Association; New York: 1997. [Google Scholar]
  • 2.Badia X., Del Llano J. La investigación de resultados en salud. Med Clin (Barc) 2000;114:1–7. [PubMed] [Google Scholar]
  • 3.Badia X., Salamero M., Alonso J. La medida de la salud. Guía de escalas de medición en español. Edimac; Barcelona: 1999. [Google Scholar]
  • 4.Badia X., Rovira J. Introducción a la evaluación económica de medicamentos y otras tecnologías sanitarias. Luzán 5 de Ediciones; Madrid: 1995. [Google Scholar]
  • 5.Bailit H., Federico J., McGivney W., for AETA health plans Use of outcomes studies by a managed care organization: valuing measured treatment effects. Med Care. 1995;33:216–225. [PubMed] [Google Scholar]
  • 6.Clancy C.M., Eisenberg J.M. Outcomes Research: measuring the end results of health care. Science. 1998;282:245–246. doi: 10.1126/science.282.5387.245. [DOI] [PubMed] [Google Scholar]
  • 7.Freund D., Lave J., Clancy C., Hawker G., Hasselblad V., Keller R. Patient outcomes research teams: contribution to outcomes and effectiveness research. Annu Rev Public Health. 1999;20:337–359. doi: 10.1146/annurev.publhealth.20.1.337. [DOI] [PubMed] [Google Scholar]
  • 8.Horwitz R.I., Viscoli C.M., Clemens J.D., Sa-dock R.T. Developing improved methods for evaluating therapeutic effectiveness. Am J Med. 1990;89:630–638. doi: 10.1016/0002-9343(90)90182-d. [DOI] [PubMed] [Google Scholar]
  • 9.Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312:1215–1218. doi: 10.1136/bmj.312.7040.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hallan S., Asberg A., Indredawick B., Wideroe T.E. Quality of life after cerebrovascular stroke: a systematic study of patients’ preferences for different functional outcomes. J Intern Med. 1999;246:309–314. doi: 10.1046/j.1365-2796.1999.00531.x. [DOI] [PubMed] [Google Scholar]
  • 11.Pearlman R.A., Uhlman R.F. Quality of life in chronic diseases: perception of elderly patients. J Gerontol. 1988;43:25–30. doi: 10.1093/geronj/43.2.m25. [DOI] [PubMed] [Google Scholar]
  • 12.Chassin M.R., Kosecoff J., Park R.E., Winslow C.M., Kahn K.L. Does appropriate use explain geographic variations in the use of health services? A study of three procedures. J Am Med Assoc. 1987;258:2533–2537. [PubMed] [Google Scholar]
  • 13.D’Agostino R.B., Kwan H. Measuring effectiveness. What to expect without a randomized control group. Med Care. 1995;33:AS95–105. [PubMed] [Google Scholar]
  • 14.Sacristán J.A., Soto J., Galende I. Evaluación de la efectividad mediante asignación aleatoria utilizando bases de datos: ¿evidencia basada en la medicina? Med Clin (Barc) 1998;111:623–627. [PubMed] [Google Scholar]
  • 15.Soto J., Sacristán A., Galende I. Estudios naturalísticos para valorar la efectividad de los medicamentos tras su comercialización: ¿por qué, cúando y cómo? Aten Primaria. 1998;22:182–185. [PubMed] [Google Scholar]
  • 16.Concato J., Shah N., Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887–1892. doi: 10.1056/NEJM200006223422507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Benson K., Hartz A.J. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878–1886. doi: 10.1056/NEJM200006223422506. [DOI] [PubMed] [Google Scholar]
  • 18.Capellà D., Bosch M. Estatinas: ¿beneficio o riesgo? Med Clin (Barc) 2002;118:335–336. doi: 10.1016/s0025-7753(02)72378-6. [DOI] [PubMed] [Google Scholar]
  • 19.Roland M., Torgerson D.J. Understanding controlled trials: what are pragmatic trials? BMJ. 1998;316:285. doi: 10.1136/bmj.316.7127.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gum P.A., Thamilarasan M., Watanabe J., Blackstone E.H., Lauer M.S. Aspirin use and all-cause mortality among patients being evaluated for know or suspected coronary artery disease. JAMA. 2001;286:1187–1194. doi: 10.1001/jama.286.10.1187. [DOI] [PubMed] [Google Scholar]
  • 21.Grandes G. ¿Por qué tan pocos ensayos clínicos en atención primaria? Aten Primaria. 2002;29:97–100. doi: 10.1016/S0212-6567(02)70513-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Roper W., Winkenwerder W., Hackbarth G., Rakauer H. Effectiveness in health care: an initiative to evaluate and improve medical practice. N Engl J Med. 1988;319:1197–1202. doi: 10.1056/NEJM198811033191805. [DOI] [PubMed] [Google Scholar]
  • 23.Agencia Española del Medicamento. Disponible en: http//www.msc.es/agemed/princip.htm

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES